Search PDMR transactions

Notifier
Name of person with notification obligation
Alsakali Equity AB
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Alsakali Equity AB
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Newbury Pharmaceuticals AB
Issuer´s LEI code
549300F7XHU3I8CWL373
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Newbury Pharmaceuticals AB SE0015244884 Acquisition 25,859 Quantity 1.59 SEK 18/11/2025 FIRST NORTH SWEDEN
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Newbury Pharmaceuticals AB SE0015244884 Acquisition 18/11/2025 FIRST NORTH SWEDEN 25,859 (Quantity) 1.59 SEK
Total: 25,859
<< Back